OMV-OspA vaccine (Intravacc)

N/A

Report date: 2025/03/20 09:57:51

Base Information

Drug NameOMV-OspA vaccine (Intravacc)

Drug Alias NameNeisseria meningitidis group B outer membrane vesicles based Lyme vaccine (Intravacc)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsLyme Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIntravacc BV

China Registration ClassN/A

Develop Information

Active CompaniesIntravacc BV

Inactive CompaniesN/A

Active IndicationsLyme Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A